サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435056

抗ミュラーリアンホルモン検査市場：製品、エンドユーザー、流通、用途別-世界予測2024-2030年

Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗ミュラーリアンホルモン検査市場：製品、エンドユーザー、流通、用途別-世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗ミュラーリアンホルモン検査市場規模は2023年に2億7,426万米ドルと推定され、2024年には3億541万米ドルに達すると予測され、CAGR 11.46%で2030年には5億8,648万米ドルに達する見込みです。

抗ミュラーリアンホルモン検査の世界市場

主な市場の統計
基準年[2023］ 2億7,426万米ドル
予測年[2024] 3億541万米ドル
予測年 [2030] 5億8,648万米ドル
CAGR（%） 11.46%
抗ミュラーリアンホルモン検査 Market-IMG1

抗ミュラーホルモン（AMH）検査は、医療専門家が女性の卵巣予備能、受胎可能性、生殖の健康を評価するために利用する診断ツールです。AMHは卵巣の前周期卵胞および肛門側卵胞の顆粒膜細胞によって産生される糖タンパク質ホルモンで、成長過程にある始原卵胞の卵胞への加入を阻害することにより、卵胞発育の調節に重要な役割を果たしています。AMH値を測定することで、女性の卵巣予備能を知ることができ、健康な胚に発育する可能性のある卵子の数を知ることができます。AMH検査はまた、多嚢胞性卵巣症候群（PCOS）の診断にも臨床的に有用です。多嚢胞性卵巣症候群は、月経不順や不妊症のリスクを高める一般的な内分泌疾患です。AMH検査は、化学療法や骨盤内放射線療法などの治療を受けているがん患者において、早発卵巣不全（POI）や早期閉経のリスクを評価するための貴重なツールです。これらの治療前、治療中、治療後のAMH値をモニターすることは、POIのリスクが高い患者を特定し、妊孕性の選択肢を維持するための適切な対策を導くのに役立ちます。さらに、女性の健康疾患の増加や、体外受精や卵子凍結療法の増加により、AMH検査の必要性が高まっています。しかし、家庭内診断キットの結果に一貫性がなく、償還方法が不明確であることが、AMH検査の採用を大きく妨げています。さらに、更年期状態におけるAMH検査のFDA承認や、自動AMH検査の新興国市場での採用が、市場開拓に大きな機会をもたらすと期待されています。

地域別インサイト

南北アメリカでは、不妊に対する関心の高まり、研究開発（R&D）の努力の高まり、FDAによるAMHの承認件数の急増により、AMH市場は大幅な成長を遂げています。米国とカナダは、製品開発と女性の不妊症の増加により、AMH市場の地域別展望をリードしています。メキシコ、アルゼンチン、ブラジルでは、急速な都市化プロセスが不妊症の減少に大きく寄与しており、主にこの国の著しい社会的、経済的、政治的変革がAMH検査市場の成長にさらに貢献しています。アジア太平洋では、不妊治療センター＆研究所の増加、国民の意識、ヘルスケア＆関連インフラへの投資、AMH検査に対する政府の支援政策により、AMH検査市場は大きく成長すると予想されます。中国、日本、インド、オーストラリア、シンガポールなどの主要国では、女性の不妊治療に対する需要と導入が増加しており、明るい展望が開けています。一方、中東・アフリカでは、UAE、サウジアラビア、南アフリカなどの主要経済国が、ヘルスケア分野におけるいくつかの開発を徐々に進めています。さらに、政府が支援策を提供することに注力し、民間ヘルスケアや製薬会社からの認知度や投資を高めることで、EMEA地域における市場の可能性が拡大すると期待されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、抗ミュラーリアンホルモン検査市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、抗ミュラーリアンホルモン検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-抗ミュラーリアンホルモン検査市場の市場規模および予測は？

2-抗ミュラーリアンホルモン検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-抗ミュラーリアンホルモン検査市場における技術動向と規制の枠組みは？

4-抗ミュラーリアンホルモン検査市場における主要ベンダーの市場シェアは？

5-抗ミュラーリアンホルモン検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 多嚢胞性卵巣症候群などの女性の健康疾患の増加
      • 体外受精と卵子凍結手術の増加により、女性の妊孕性に関する健康診断が求められている
    • 抑制要因
      • 不明確な償還オプション
    • 機会
      • 更年期障害におけるAMH検査の新たなFDA承認
      • 自動AMH検査の導入が拡大
    • 課題
      • 家庭用診断キットに関連する結果の不一致
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 抗ミュラーリアンホルモン検査市場：製品別

  • POCテスト
  • セルフチェックキット
    • ELISAキット
    • 迅速検査キット

第7章 抗ミュラーリアンホルモン検査市場：エンドユーザー別

  • 商業研究所
  • 研究開発

第8章 抗ミュラーリアンホルモン検査市場配信別

  • オフラインチャネル
  • オンラインチャネル

第9章 抗ミュラーリアンホルモン検査市場用途別

  • 人間
  • 非人間

第10章 南北アメリカの抗ミュラーリアンホルモン検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の抗ミュラーリアンホルモン検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの抗ミュラーリアンホルモン検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbexa Ltd.
    • Ansh Labs
    • Athenese-Dx
    • BioMerieux SA
    • Chengdu VACURE Biotechnology Co., Ltd.
    • CTK Biotech, Inc.
    • Cusabio Technology LLC
    • Danaher Corporation
    • Doctorcall Limited
    • Eagle Biosciences, Inc.
    • Elabscience, Inc.
    • enQuire Bio, LLC
    • F. Hoffmann-La Roche AG
    • Fertility 2 U Ltd
    • Goldsite Diagnostics Inc.
    • Kamiya Biomedical Co
    • LifeSpan BioSciences, Inc.
    • London Gynaecology Ltd.
    • Meridian Life Science, Inc. by SD Biosensor
    • Monobind Inc.
    • Tosoh Corporation
    • Vitall by Healthy Human Labs Ltd.
    • Vitrosens Biotechnology
    • Walk-In Lab, LLC
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
  • FIGURE 7. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 12. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2030 (%)
  • FIGURE 14. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 9. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 18. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 129. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 134. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 139. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 144. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 149. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 154. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 159. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 164. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 169. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 174. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 179. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 184. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 189. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 199. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 204. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 209. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 214. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 219. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 229. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 230. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 231. ANTI-MULLERIAN HORMONE TEST MARKET LICENSE & PRICING
目次
Product Code: MRR-BC3400CDF7C4

[184 Pages Report] The Anti-Mullerian Hormone Test Market size was estimated at USD 274.26 million in 2023 and expected to reach USD 305.41 million in 2024, at a CAGR 11.46% to reach USD 586.48 million by 2030.

Global Anti-Mullerian Hormone Test Market

KEY MARKET STATISTICS
Base Year [2023] USD 274.26 million
Estimated Year [2024] USD 305.41 million
Forecast Year [2030] USD 586.48 million
CAGR (%) 11.46%
Anti-Mullerian Hormone Test Market - IMG1

The anti-mullerian hormone (AMH) test is a diagnostic tool healthcare professionals utilize to evaluate ovarian reserve, fertility potential, and reproductive health in women. AMH is a glycoprotein hormone created by the granulosa cells of pre-antral and antral follicles in the ovaries which plays a crucial role in regulating follicular development by inhibiting the recruitment of primordial follicles into the growing pool. Measuring AMH levels provides valuable insights into a woman's ovarian reserve, which directs to the number of eggs that can potentially develop into healthy embryos. The AMH test also has clinical utility in diagnosing polycystic ovary syndrome (PCOS), a common endocrine disorder causing irregular menstrual cycles and increased risk of infertility. AMH testing serves as an invaluable tool for assessing the risk of premature ovarian insufficiency (POI) or early menopause in cancer patients undergoing treatments such as chemotherapy or pelvic radiation therapy. Monitoring AMH levels before, during, and after these therapies help identify individuals at higher risk for POI and guide appropriate measures to preserve their fertility options. Moreover, the rising number of women's health diseases and the growing number of IVF and egg-freezing procedures raised the need for AMH tests. However, inconsistent results of in-home diagnostics kits and unclear reimbursement options significantly impede the adoption of AMH tests. In addition, emerging FDA approval of AMH test in menopausal status and the emerging adoption of automated AMH tests is expected to create tremendous opportunities for market development.

Regional Insights

In the Americas, the anti-mullerian hormone test market has experienced substantial growth due to increasing infertility concerns, rising research and development (R&D) efforts, and the surging number of approvals in AMH by the FDA in the recent period. The U.S. and Canada are heading the regional AMH market landscape with product development and increased infertility in women. In Mexico, Argentina, and Brazil, the rapid urbanization process significantly contributes to the fertility decrease, primarily linked to the country's significant social, economic, and political transformations, further contributing to the AMH test market growth. In the Asia-Pacific, the AMH test market is expected to grow significantly due to increasing infertility treatment centers & laboratories, awareness among the population, investment in healthcare & related infrastructure, and supportive government policies for AMH tests. The major economies, including China, Japan, India, Australia, and Singapore, offer positive prospects with increasing demand and adoption of female fertility care. In the EMEA region, the developed European economies represent the advanced landscape, whereas, in the Middle East & Africa, the major economies such as UAE, Saudi Arabia, and South Africa are gradually moving ahead with several developments in the healthcare sector. Moreover, rising governments focus on providing supportive measures and raising awareness and investment from private healthcare, and pharmaceutical companies are expected to expand the market's potential in the EMEA region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anti-Mullerian Hormone Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anti-Mullerian Hormone Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Ltd., Ansh Labs, Athenese-Dx, BioMerieux SA, Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Danaher Corporation, Doctorcall Limited, Eagle Biosciences, Inc., Elabscience, Inc., enQuire Bio, LLC, F. Hoffmann-La Roche AG, Fertility 2 U Ltd, Goldsite Diagnostics Inc., Kamiya Biomedical Co, LifeSpan BioSciences, Inc., London Gynaecology Ltd., Meridian Life Science, Inc. by SD Biosensor, Monobind Inc., Tosoh Corporation, Vitall by Healthy Human Labs Ltd., Vitrosens Biotechnology, and Walk-In Lab, LLC.

Market Segmentation & Coverage

This research report categorizes the Anti-Mullerian Hormone Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • POC Testing
    • Self-check Kits
      • ELISA Kits
      • Rapid Test Kit
  • End-User
    • Commercial Labs
    • Research & development
  • Distribution
    • Offline Channels
    • Online Channels
  • Use
    • Human
    • Non-Human
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anti-Mullerian Hormone Test Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anti-Mullerian Hormone Test Market?

3. What are the technology trends and regulatory frameworks in the Anti-Mullerian Hormone Test Market?

4. What is the market share of the leading vendors in the Anti-Mullerian Hormone Test Market?

5. Which modes and strategic moves are suitable for entering the Anti-Mullerian Hormone Test Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anti-Mullerian Hormone Test Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Number of Women's Health Diseases such as Polycystic Ovarian Syndrome
      • 5.1.1.2. Growing Number of IVF and Egg Freezing Procedures Demand Medical Check-up of Women Fertility
    • 5.1.2. Restraints
      • 5.1.2.1. Unclear Reimbursement Options
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging FDA approval of AMH test in Menopausal Status
      • 5.1.3.2. Growing Adoption of Automated AMH Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Result Inconsistencies Associated with In-home Diagnostics Kits
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anti-Mullerian Hormone Test Market, by Product

  • 6.1. Introduction
  • 6.2. POC Testing
  • 6.3. Self-check Kits
    • 6.4.1. ELISA Kits
    • 6.4.2. Rapid Test Kit

7. Anti-Mullerian Hormone Test Market, by End-User

  • 7.1. Introduction
  • 7.2. Commercial Labs
  • 7.3. Research & development

8. Anti-Mullerian Hormone Test Market, by Distribution

  • 8.1. Introduction
  • 8.2. Offline Channels
  • 8.3. Online Channels

9. Anti-Mullerian Hormone Test Market, by Use

  • 9.1. Introduction
  • 9.2. Human
  • 9.3. Non-Human

10. Americas Anti-Mullerian Hormone Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-Mullerian Hormone Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Quest and Proov Collaborate to Bring Novel Home Fertility Test to Women Through questhealth.com
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. LifeCell Launches Advanced Self Collection Healthcare Services
    • 13.3.3. Investment & Funding
      • 13.3.3.1. Eli Raises USD 5 Million to Make At-Home Hormone Testing for Women more Accessible

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbexa Ltd.
    • 14.1.2. Ansh Labs
    • 14.1.3. Athenese-Dx
    • 14.1.4. BioMerieux SA
    • 14.1.5. Chengdu VACURE Biotechnology Co., Ltd.
    • 14.1.6. CTK Biotech, Inc.
    • 14.1.7. Cusabio Technology LLC
    • 14.1.8. Danaher Corporation
    • 14.1.9. Doctorcall Limited
    • 14.1.10. Eagle Biosciences, Inc.
    • 14.1.11. Elabscience, Inc.
    • 14.1.12. enQuire Bio, LLC
    • 14.1.13. F. Hoffmann-La Roche AG
    • 14.1.14. Fertility 2 U Ltd
    • 14.1.15. Goldsite Diagnostics Inc.
    • 14.1.16. Kamiya Biomedical Co
    • 14.1.17. LifeSpan BioSciences, Inc.
    • 14.1.18. London Gynaecology Ltd.
    • 14.1.19. Meridian Life Science, Inc. by SD Biosensor
    • 14.1.20. Monobind Inc.
    • 14.1.21. Tosoh Corporation
    • 14.1.22. Vitall by Healthy Human Labs Ltd.
    • 14.1.23. Vitrosens Biotechnology
    • 14.1.24. Walk-In Lab, LLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing